180 related articles for article (PubMed ID: 37400085)
1. Incidence and Risk Factors of Recurrent Anterior Uveitis in Initial Acute-Onset Vogt-Koyanagi-Harada Disease.
Lim YJ; Byon I; Kim HW; Park SW; Kwon HJ; Kim E
Korean J Ophthalmol; 2023 Aug; 37(4):299-306. PubMed ID: 37400085
[TBL] [Abstract][Full Text] [Related]
2. Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals.
Iwahashi C; Okuno K; Hashida N; Nakai K; Ohguro N; Nishida K
Jpn J Ophthalmol; 2015 May; 59(3):157-63. PubMed ID: 25808016
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
Yang P; Ren Y; Li B; Fang W; Meng Q; Kijlstra A
Ophthalmology; 2007 Mar; 114(3):606-14. PubMed ID: 17123618
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.
Feng H; Chen W; Yang J; Kong H; Li H; He Y; Wang H
BMC Ophthalmol; 2024 Jun; 24(1):238. PubMed ID: 38849758
[TBL] [Abstract][Full Text] [Related]
5. Initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease presenting with unilateral exudative retinal detachment despite bilateral choroidal involvement.
AlBloushi AF; Herbort CP; Abu El-Asrar AM
Int Ophthalmol; 2021 Dec; 41(12):4187-4195. PubMed ID: 34346004
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in Vogt-Koyanagi-Harada disease.
Al-Kharashi AS; Aldibhi H; Al-Fraykh H; Kangave D; Abu El-Asrar AM
Int Ophthalmol; 2007; 27(2-3):201-10. PubMed ID: 17435968
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients.
Yang P; Liu S; Zhong Z; Du L; Ye Z; Zhou W; Kijlstra A
Ophthalmology; 2019 Sep; 126(9):1297-1305. PubMed ID: 30959067
[TBL] [Abstract][Full Text] [Related]
8. Vogt-Koyanagi-Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report.
Kikuchi R; Kawagoe T; Hotta K
BMC Ophthalmol; 2020 Jun; 20(1):252. PubMed ID: 32580711
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
Abu El-Asrar AM; Al Tamimi M; Hemachandran S; Al-Mezaine HS; Al-Muammar A; Kangave D
Acta Ophthalmol; 2013 Sep; 91(6):e486-93. PubMed ID: 23575246
[TBL] [Abstract][Full Text] [Related]
10. Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.
AlBloushi AF; Alfawaz AM; AlZaid A; Alsalamah AK; Gikandi PW; Abu El-Asrar AM
Ocul Immunol Inflamm; 2021 Jan; 29(1):128-136. PubMed ID: 31638886
[No Abstract] [Full Text] [Related]
11. Acute phase clinical manifestations of patients with Vogt-Koyanagi-Harada disease in Southern China.
Zhang C; Wang Y; Chen Y; Zhou H; Hong Q; Yu X; Ng TK; Cen LP
BMC Ophthalmol; 2023 May; 23(1):199. PubMed ID: 37147563
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
Alromaih AZ; Almater AI; Albloushi AF; Alkheraiji NF; Abu El-Asrar AM
Int Ophthalmol; 2023 Jan; 43(1):185-195. PubMed ID: 35945413
[TBL] [Abstract][Full Text] [Related]
14. Vogt-Koyanagi-Harada disease in 3-year-old boy.
Takada S; Tanaka R; Kurita N; Ishii K; Kaburaki T
Clin Exp Ophthalmol; 2015 Aug; 43(6):593-4. PubMed ID: 25711345
[No Abstract] [Full Text] [Related]
15. The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma.
Veerappan M; Fleischman D; Ulrich JN; Stinnett SS; Jaffe GJ; Allingham RR
Ocul Immunol Inflamm; 2017 Dec; 25(6):748-752. PubMed ID: 27438521
[TBL] [Abstract][Full Text] [Related]
16. The Choroidal Vascularity Index Decreases and Choroidal Thickness Increases in Vogt-Koyanagi-Harada Disease Patients During a Recurrent Anterior Uveitis Attack.
Liu S; Du L; Zhou Q; Zhang Q; Hu K; Qi J; Liang L; Zhou C; Kijlstra A; Yang P
Ocul Immunol Inflamm; 2018; 26(8):1237-1243. PubMed ID: 28914578
[TBL] [Abstract][Full Text] [Related]
17. Vogt-Koyanagi-Harada Syndrome in a Group of Patients in Two Ophthalmology Referral Centers in Bogotá, Colombia.
Guayacán CL; Galindo-Mendez B; de-la-Torre A
Ocul Immunol Inflamm; 2018; 26(7):1123-1127. PubMed ID: 28910557
[TBL] [Abstract][Full Text] [Related]
18. Incidence and pre/post-treatment risk factors of glaucoma in Vogt-Koyanagi-Harada disease.
Yoshitomi S; Harada Y; Hiyama T; Yuasa Y; Hirooka K; Kiuchi Y
Int Ophthalmol; 2023 Aug; 43(8):2857-2866. PubMed ID: 36929369
[TBL] [Abstract][Full Text] [Related]
19. Long-term Outcomes of Uveitis Associated with Vogt-Koyanagi-Harada Disease in the Pediatric Age Group.
AlBloushi AF; AlEnezi SH; Al Owaifeer AM; Al-Hadlaq OS; Gikandi PW; Abu El-Asrar AM
Ocul Immunol Inflamm; 2022; 30(7-8):1669-1677. PubMed ID: 34184966
[TBL] [Abstract][Full Text] [Related]
20. Internal Limiting Membrane Folds as a Presenting Sign in Acute Initial-Onset Vogt-Koyanagi-Harada Disease: A Case Report.
Almalki K; Alsulaiman SM; Abouammoh MA
Ocul Immunol Inflamm; 2022 Apr; 30(3):641-645. PubMed ID: 33054464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]